Search

All phases Early Phase 1 Phase 1 Phase 2 Phase 3 Phase 4 Phase 1/2 Phase 2/3

All statuses Open (recruiting or opening soon) Active, not recruiting Completed

25 miles 50 miles 100 miles 200 miles

Newest Nearest Most relevant

Apply Reset

Buspirone, in Combination With Amantadine, for the Treatment of Levodopa-induced Dyskinesia

Trial Phase 1 Terminated March 4, 2021

Multidisciplinary Health Educational Program Based on Centered People Care Model in Parkinson's Disease

Trial N/A Unknown March 4, 2021

Unilateral GPi vs Unilateral STN DBS in the Same Patient With PD

Trial N/A Completed March 3, 2021

Comparative Controlled Study of Analgesic, Antiasthenic and Anti-Anxiety Effects of Xenon in Patients With Parkinson's Disease

Trial Phase 1 Unknown March 2, 2021

Cholinergic Mechanisms of Gait Dysfunction in Parkinson's Disease

Trial N/A Completed March 1, 2021

Nabilone for Non-motor Symptoms in Parkinson's Disease

Trial Phase 2 Completed March 1, 2021

Nabilone for Non-motor Symptoms in Parkinson's Disease

Trial Phase 3 Completed March 1, 2021

A Study to Determine the Dose of WIN-1001X by Evaluating Efficacy and Safety in Early Parkinson's Disease Patients

Trial Phase 2 Unknown Feb. 23, 2021

An Exploratory Study Investigating Safety, Tolerability and Pharmacokinetics of Ascending Doses of Lu AE04621 in Parkinson Disease Patients

Trial Phase 1 Completed Feb. 23, 2021

Dental Appliance for Parkinson's Disease

Trial N/A Completed Feb. 23, 2021

Cognitive Rehabilitation for PD

Trial N/A Completed Feb. 22, 2021

Antigen Presentation and Lymphocyte Response in Parkinson's Disease

Trial N/A Completed Feb. 20, 2021

A Efficacy, Safety and Pharmacokinetic Study of XP21279 and Sinemet® in Parkinson's Disease Subjects

Trial Phase 2 Completed Feb. 17, 2021

The Effect of Kinesiophobia on Physical Activity, Balance and Falling in Parkinson's Disease Patients

Trial N/A Completed Feb. 17, 2021

Multifocal Neuromodulation in Motor and Cognitive Function of People With Parkinson's Disease

Trial N/A Unknown Feb. 16, 2021

A Clinical Study of KDT-3594 in Patients With Early Parkinson's Disease.

Trial Phase 2 Completed Feb. 16, 2021

The SUSTAIN Study Compares the Effects of Sustained and Immediate-release Pramipexole on the noctUrnal Symptoms of paTients With Advanced ParkInsoN's Disease Who Also Take L-Dopa

Trial Phase 4 Completed Feb. 15, 2021

Study of Factors Associated With the Volumetric and Areal Bone Mineral Density and Bone Strength in Parkinson's Disease

Trial N/A Unknown Feb. 15, 2021

Neural Correlates of Cognition in Parkinson's Disease

Trial N/A Completed Feb. 14, 2021

Cholinergic Mechanisms of Gait Dysfunction in Parkinson's Disease Experiments 1 & 2 - Proj #3

Trial Phase 2 Completed Feb. 11, 2021